• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促焦亡性miR-216a-5p的外泌体转移通过乳腺癌-心脏病理串扰加剧蒽环类药物心脏毒性。

Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk.

作者信息

Ma Yan, Wang Yongjun, Chen Renzheng, Wang Yabin, Fang Yan, Qin Cheng, Wang Tianhu, Shen Xiaoying, Zhou Tingwen, Tian Lei, Sun Ting, Fan Li, Wang Xiaoning, Han Dong, Cao Feng

机构信息

Chinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General Hospital, 100853, Beijing, China.

Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.

出版信息

Signal Transduct Target Ther. 2025 May 14;10(1):157. doi: 10.1038/s41392-025-02245-4.

DOI:10.1038/s41392-025-02245-4
PMID:40360476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12075849/
Abstract

Doxorubicin (DOX) is the most effective chemotherapeutic for breast cancer, but it is usually associated with severe cardiotoxicity. Further investigation to alleviate its side effects is essential. The present study investigated the mechanism of the cross-organ communication between tumors and the heart and potential intervention targets. Morphological bubble-like protrusions were observed in both adult murine ventricular cardiomyocytes (AMVCs) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) cocultured with breast cancer cells (BCCs), along with elevated expression of pyroptosis-related proteins. Exosomes (EXOs) from DOX-treated BCCs aggravated DOX-induced cardiotoxicity (DOXIC) in an orthotopic mouse model of breast cancer. Blocking miRNAs by knocking down Rab27a or inhibiting the release of EXOs in cancer tissue by Dicer enzyme knockout attenuated this additional injury effect. Exosomal miRNA sequencing revealed that miR-216a-5p is especially upregulated in EXOs from DOX-induced BCCs. Mechanistically, miR-216a-5p was upregulated by enhanced transcription mediated by DOX-induced AMP-dependent transcription factor 3 (ATF3) and packaged into EXOs by splicing factor 3b subunit 4 (SF3B4) in BCCs. Itchy E3 ubiquitin-protein ligase (ITCH) was identified as a novel downstream target mRNA of miR-216a-5p. ITCH negatively mediated thioredoxin-interacting protein (TXNIP) ubiquitination to activate the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome pathway, ultimately leading to cardiomyocyte pyroptosis. Our findings revealed novel cross-organ pathogenic communication between breast cancer and the heart through the exosomal miR-216a-5p-mediated ITCH/TXNIP/NLRP3 pathway, which drives cardiomyocyte pyroptosis. These findings suggest that targeting myocardial miR-216a-5p or blocking harmful EXOs from breast cancer is a potential therapeutic strategy for alleviating DOXIC.

摘要

多柔比星(DOX)是治疗乳腺癌最有效的化疗药物,但它通常与严重的心脏毒性相关。进一步研究减轻其副作用至关重要。本研究调查了肿瘤与心脏之间跨器官通讯的机制以及潜在的干预靶点。在与乳腺癌细胞(BCCs)共培养的成年小鼠心室心肌细胞(AMVCs)和人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)中均观察到形态学上的气泡样突起,同时焦亡相关蛋白的表达升高。来自多柔比星处理的BCCs的外泌体(EXOs)在乳腺癌原位小鼠模型中加重了多柔比星诱导的心脏毒性(DOXIC)。通过敲低Rab27a阻断微小RNA(miRNAs)或通过Dicer酶敲除抑制癌症组织中外泌体的释放可减轻这种额外的损伤作用。外泌体微小RNA测序显示,miR-216a-5p在多柔比星诱导的BCCs来源的外泌体中尤其上调。机制上,miR-216a-5p通过多柔比星诱导的AMP依赖转录因子3(ATF3)介导的转录增强而上调,并由BCCs中的剪接因子3b亚基4(SF3B4)包装到外泌体中。瘙痒E3泛素蛋白连接酶(ITCH)被鉴定为miR-216a-5p的一个新的下游靶标mRNA。ITCH负向介导硫氧还蛋白相互作用蛋白(TXNIP)的泛素化,以激活含NOD、LRR和吡啉结构域的蛋白3(NLRP3)炎性小体途径,最终导致心肌细胞焦亡。我们的研究结果揭示了乳腺癌与心脏之间通过外泌体miR-216a-5p介导的ITCH/TXNIP/NLRP3途径存在新的跨器官致病通讯,该途径驱动心肌细胞焦亡。这些发现表明,靶向心肌miR-216a-5p或阻断来自乳腺癌的有害外泌体是减轻DOXIC的一种潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/0c5265eeaec2/41392_2025_2245_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/84d6c7828ae9/41392_2025_2245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/bec723d9cd52/41392_2025_2245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/23355de74f65/41392_2025_2245_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/037d2d5a3b97/41392_2025_2245_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/abda3112378b/41392_2025_2245_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/a9b235a8d75f/41392_2025_2245_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/868ebeb8f279/41392_2025_2245_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/c9ad8704df9e/41392_2025_2245_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/89f811f8d345/41392_2025_2245_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/83a1a8eea958/41392_2025_2245_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/0c5265eeaec2/41392_2025_2245_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/84d6c7828ae9/41392_2025_2245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/bec723d9cd52/41392_2025_2245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/23355de74f65/41392_2025_2245_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/037d2d5a3b97/41392_2025_2245_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/abda3112378b/41392_2025_2245_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/a9b235a8d75f/41392_2025_2245_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/868ebeb8f279/41392_2025_2245_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/c9ad8704df9e/41392_2025_2245_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/89f811f8d345/41392_2025_2245_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/83a1a8eea958/41392_2025_2245_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/023d/12075849/0c5265eeaec2/41392_2025_2245_Fig11_HTML.jpg

相似文献

1
Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk.促焦亡性miR-216a-5p的外泌体转移通过乳腺癌-心脏病理串扰加剧蒽环类药物心脏毒性。
Signal Transduct Target Ther. 2025 May 14;10(1):157. doi: 10.1038/s41392-025-02245-4.
2
The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.抑癌性人类环状 RNA CircITCH 通过海绵吸附 miR-330-5p 来上调 SIRT6、Survivin 和 SERCA2a 以减轻阿霉素诱导的心脏毒性。
Circ Res. 2020 Jul 31;127(4):e108-e125. doi: 10.1161/CIRCRESAHA.119.316061. Epub 2020 May 11.
3
Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.胚胎干细胞衍生的外泌体抑制多柔比星诱导的 TLR4-NLRP3 介导的细胞死亡-焦亡。
Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H460-H471. doi: 10.1152/ajpheart.00056.2019. Epub 2019 Jun 7.
4
Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome.脂肪间充质干细胞来源的外泌体 miR-17-5p 通过抑制 TXNIP-NLRP3 炎性小体抑制腹主动脉瘤。
Stem Cell Res Ther. 2022 Jul 26;13(1):349. doi: 10.1186/s13287-022-03037-1.
5
Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.多柔比星通过 TINCR 介导的含 NOD 样受体家族 pyrin 结构域蛋白 3 的转录后稳定化诱导心肌细胞细胞焦亡。
J Mol Cell Cardiol. 2019 Nov;136:15-26. doi: 10.1016/j.yjmcc.2019.08.009. Epub 2019 Aug 21.
6
M2 macrophage derived exosomal miR-20a-5p ameliorates trophoblast pyroptosis and placental injuries in obstetric antiphospholipid syndrome via the TXNIP/NLRP3 axis.M2巨噬细胞衍生的外泌体miR-20a-5p通过TXNIP/NLRP3轴改善产科抗磷脂综合征中的滋养层细胞焦亡和胎盘损伤。
Life Sci. 2025 Jun 1;370:123561. doi: 10.1016/j.lfs.2025.123561. Epub 2025 Mar 22.
7
Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence.外泌体 miR-9-5p 来源于 iPSC-MSCs,通过抑制心肌细胞衰老改善多柔比星诱导的心肌病。
J Nanobiotechnology. 2024 Apr 20;22(1):195. doi: 10.1186/s12951-024-02421-8.
8
Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.阿魏酸通过抑制 STING/NLRP3 信号通路抑制心肌细胞焦亡和炎症减轻多柔比星诱导的心脏毒性。
Phytomedicine. 2023 Aug;117:154922. doi: 10.1016/j.phymed.2023.154922. Epub 2023 Jun 10.
9
LncRNA GHET1 from bone mesenchymal stem cell-derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3.骨间充质干细胞来源的外泌体中的长链非编码 RNA GHET1 通过介导 NLRP3 改善阿霉素诱导的心肌细胞细胞焦亡。
Sci Rep. 2024 Aug 17;14(1):19078. doi: 10.1038/s41598-024-70151-w.
10
Thiolutin Alleviates Cardiotoxic Effects of Doxorubicin by Suppressing NLRP3 Inflammasome in the Mouse Model.硫藤黄菌素通过抑制小鼠模型中的NLRP3炎性小体减轻阿霉素的心脏毒性作用。
Cardiovasc Toxicol. 2025 Feb;25(2):182-192. doi: 10.1007/s12012-024-09947-1. Epub 2024 Dec 11.

引用本文的文献

1
Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update.阿霉素诱导的心脏毒性:全面更新
J Cardiovasc Dev Dis. 2025 May 30;12(6):207. doi: 10.3390/jcdd12060207.

本文引用的文献

1
Breast cancer and cardiovascular health.乳腺癌与心血管健康。
Eur Heart J. 2024 Nov 7;45(41):4366-4382. doi: 10.1093/eurheartj/ehae637.
2
A focus on two rapidly expanding fields: cardio-oncology and genetics.关注两个迅速发展的领域:心脏肿瘤学和遗传学。
Eur Heart J. 2024 Sep 7;45(34):3095-3099. doi: 10.1093/eurheartj/ehae556.
3
Insights into non-coding RNAS: biogenesis, function and their potential regulatory roles in acute kidney disease and chronic kidney disease.非编码RNA研究进展:生物合成、功能及其在急性肾损伤和慢性肾脏病中的潜在调控作用
Mol Cell Biochem. 2025 Mar;480(3):1287-1304. doi: 10.1007/s11010-024-05083-0. Epub 2024 Aug 7.
4
Cardiac wasting and cancer.心脏消耗与癌症。
Eur Heart J. 2024 Sep 7;45(34):3135-3137. doi: 10.1093/eurheartj/ehae438.
5
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.来自梗死和衰竭心脏的小细胞外囊泡加速肿瘤生长。
Circulation. 2024 May 28;149(22):1729-1748. doi: 10.1161/CIRCULATIONAHA.123.066911. Epub 2024 Mar 15.
6
MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer.MALAT1通过竞争性结合miR-216a-5p促进FOXA1降解,并增强前列腺癌的神经内分泌分化。
Transl Oncol. 2024 Jan;39:101807. doi: 10.1016/j.tranon.2023.101807. Epub 2023 Oct 28.
7
Ginsenoside Rb2 improves heart failure by down-regulating miR-216a-5p to promote autophagy and inhibit apoptosis and oxidative stress.人参皂苷 Rb2 通过下调 miR-216a-5p 来改善心力衰竭,从而促进自噬并抑制细胞凋亡和氧化应激。
J Appl Biomed. 2023 Dec;21(4):180-192. doi: 10.32725/jab.2023.024. Epub 2023 Dec 14.
8
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.细胞外囊泡与心血管疾病:从病理生理学到诊断与治疗。
Cytokine Growth Factor Rev. 2023 Dec;74:40-55. doi: 10.1016/j.cytogfr.2023.09.006. Epub 2023 Sep 28.
9
Extracellular vesicle-mediated interorgan communication in metabolic diseases.细胞外囊泡介导的代谢疾病中的器官间通讯。
Trends Endocrinol Metab. 2023 Sep;34(9):571-582. doi: 10.1016/j.tem.2023.06.002. Epub 2023 Jun 30.
10
Molecular mechanisms of microRNA-216a during tumor progression.微小RNA-216a在肿瘤进展过程中的分子机制。
Cancer Cell Int. 2023 Feb 5;23(1):19. doi: 10.1186/s12935-023-02865-2.